Same-Day Antiretroviral Therapy Initiation

Primary outcomes

1. Acceptance

   Time frame: 5 years

   Acceptance of Same-Day ART

2. Type of Clients

   Time frame: 5 years

   Type of Clients (newly diagnosed or re-engaged)

3. Number of clients categorized by demographic characteristics

   Time frame: 5 years

   Demographic Characteristics: age (years), gender (sex at birth and gender identity), risk behavior(s), and reason(s) for HIV testing

4. Number of clients with each clinical characteristic

   Time frame: 5 years

   Clinical Characteristics based on Thailand's national guidelines (anti-HIV, creatinine, alanine transaminase, syphilis serology, hepatitis B antigen, hepatitis C antibodies, urinalysis, chest X-ray, CD4 count, CDC stage, comorbidity)

5. Number of clients with each ART drug regimen differ from first line ART regimen

   Time frame: 5 years

   Drug regimen, if different from first line drug (TDF, FTC, EFV)

6. Duration between date of HIV diagnosis and date of ART initiation

   Time frame: 5 years

   Duration between date of HIV diagnosis and date of ART initiation

7. Number of clients with each clinical exclusion criteria

   Time frame: 5 years

   Clinical exclusion criterias : suspected TB, suspected cryptococcal meningitis, suspected serious OIs

8. Duration between date of ART initiation to date of being successfully transferred and date of ART continuation

   Time frame: 5 years

   Duration of linkage to care, if applicable (date of being successfully transferred and date of ART continuation)

9. Retention

   Time frame: 5 years

   Retention (retention in care, discontinued ART, loss to follow-up, death) at month 1, month 3, month 6, and month 12 after ART initiation

10. Viral load count

    Time frame: 5 years

    Viral load count (VL tested, percentage of VL suppressed, and dates of VL suppressed)